Who
Michael Allen Jerman
Director
Company insider
Files Form 4 as: Director, Alaunos Therapeutics; Director, Inhibitor Therapeutics; Director, Telomir Pharmaceuticals; Director, MIRA Pharmaceuticals.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 25 Mar 2024
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K20,990 at $0.7444 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K8,138 at $1.92 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K8,138 at $1.92 | filing |
| 4 May 2026filed 24 Jun 2026 | Inhibitor Therapeutics | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 29 Apr 2026filed 1 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K6,032 at $2.59 | filing |
| 29 Apr 2026filed 1 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K6,032 at $2.59 | filing |
| 12 Jan 2026filed 15 Jan 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,406 at $2.89 | filing |
| 12 Jan 2026filed 15 Jan 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K5,406 at $2.89 | filing |
| 21 Nov 2025filed 26 Nov 2025 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K4,183 at $3.16 | filing |
| 15 Jul 2025filed 17 Jul 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Jul 2025filed 17 Jul 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
| 1 Apr 2025filed 7 Apr 2025 | Inhibitor Therapeutics | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 27 Aug 2024filed 29 Aug 2024 | TELO Telomir Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Apr 2024filed 16 May 2024 | Inhibitor Therapeutics | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | MIRA MIRA Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.